Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 6/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380049 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL379519 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL15229291 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL719001 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| Ocrylate SCHEMBL29891 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL2903638 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL29340 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL973728 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL3457991 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 | |
| SCHEMBL7744948 | 1.00 | TSHR (0.62) | TSHRALDH1A1NAAARAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 555 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| US-20260060402-A1 | REMOVABLE NAIL COATINGS AND COMPOSITIONS AND METHODS OF PREPARING THEREOF | LIQWD INC (US) | 2026-03-05 | — | — | US | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| EP-4504844-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2025-02-12 | — | — | EP | claimed |
| CN-117062636-A | Catheter securement compositions and methods | 艾德合森生物医药有限责任公司 | 2023-11-14 | — | — | CN | claimed |
| WO-2023194367-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2023-10-12 | — | — | WO | claimed |
| EP-4257648-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2023-10-11 | — | — | EP | claimed |
| EP-3513744-B1 | MESH DISPENSER | ETHICON INC (US) | 2022-11-16 | — | — | EP | claimed |
| EP-1265851-A2 | TRANSESTERIFICATION METHOD FOR MAKING CYANOACRYLATES | Closure Medical Corporation (US) | 2002-12-18 | — | — | EP | claimed |
| WO-2002020069-A2 | ANTIOXIDANT ENRICHED ADHESIVE COMPOSITIONS AND STORAGE CONTAINERS THEREFOR | CLOSURE MEDICAL CORPORATION (US) | 2002-03-14 | — | — | WO | claimed |
| US-6245933-B1 | CONDENSING A CYANOACETATE WITH PARAFORMALDEHYDE OR FORMALDEHYDE, REACTING THE POLYMER FORMED WITH AN ALCOHOL, AND DEPOLYMERIZING THE POLYMER TO FORM ALPHA-CYANOACRYLATE MONOMERS | CLOSURE MEDICAL CORPORATION | 2001-06-12 | — | — | US | claimed |
| WO-2001036380-A2 | TRANSESTERIFICATION METHOD FOR MAKING CYANOACRYLATES | CLOSURE MEDICAL CORPORATION (US) | 2001-05-25 | — | — | WO | claimed |
| US-5981621-A | COMPRISING AT LEAST ONE MONOMER, WHICH FORMS A MEDICALLY ACCEPTABLE POLYMER, AT LEAST ONE PLASTICIZING AGENT, AT LEAST ONE ACIDIC STABILIZING AGENT, AN INITIATOR | CLOSURE MEDICAL CORPORATION (US) | 1999-11-09 | — | — | US | claimed |
| CN-1213285-A | Monomer composition for wound closure | CLOSURE MEDICAL CORP (US) | 1999-04-07 | — | — | CN | claimed |
| US-4393183-A | STORAGE STABILITY, BONDING STRENGTH | TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-07-12 | — | — | US | claimed |
| US-4313865-A | A Z-CYANOACRYLATE AND A 1,1-OISUBSTITUTED DIENE PROVIDES FLEXIBILITY, HEAT RESISTANCE, IMPACT RESISTANCE, PEEL RESISTANCE AND WATER RESISTANCE | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1982-02-02 | — | — | US | claimed |
| EP-0026665-A1 | Quick-setting adhesive composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-04-08 | — | — | EP | claimed |
| US-4180913-A | SILICA POWDER COATED WITH AMINO ACID AND ACID-AMIDE COMPOUND CATALYST | LION HAMIGAKI KABUSHIKI KAISHA (JP) | 1980-01-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060402-A1 | REMOVABLE NAIL COATINGS AND COMPOSITIONS AND METHODS OF PREPARING THEREOF | POLR1C, PRKDC, PIK3C3 | TSHR 691/4885ALDH1A1 2519/4885NAAA 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.